200 related articles for article (PubMed ID: 33899015)
1. Generating mutant
Li HH; Li JC; Su MP; Liu KL; Chen CH
STAR Protoc; 2021 Jun; 2(2):100432. PubMed ID: 33899015
[TBL] [Abstract][Full Text] [Related]
2. Germline Cas9 expression yields highly efficient genome engineering in a major worldwide disease vector,
Li M; Bui M; Yang T; Bowman CS; White BJ; Akbari OS
Proc Natl Acad Sci U S A; 2017 Dec; 114(49):E10540-E10549. PubMed ID: 29138316
[TBL] [Abstract][Full Text] [Related]
3. A selectable, plasmid-based system to generate CRISPR/Cas9 gene edited and knock-in mosquito cell lines.
Rozen-Gagnon K; Yi S; Jacobson E; Novack S; Rice CM
Sci Rep; 2021 Jan; 11(1):736. PubMed ID: 33436886
[TBL] [Abstract][Full Text] [Related]
4. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
Albadri S; Del Bene F; Revenu C
Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Mediated Genome Engineering in Aedes aegypti.
Sun R; Li M; McMeniman CJ; Akbari OS
Methods Mol Biol; 2022; 2509():23-51. PubMed ID: 35796955
[TBL] [Abstract][Full Text] [Related]
6. Optimized protocol for gene editing in adipocytes using CRISPR-Cas9 technology.
Qiu Y; Ding Q
STAR Protoc; 2021 Mar; 2(1):100307. PubMed ID: 33554142
[TBL] [Abstract][Full Text] [Related]
7. Gene Disruption Using CRISPR-Cas9 Technology.
Hu N; Malek SN
Methods Mol Biol; 2019; 1881():201-209. PubMed ID: 30350208
[TBL] [Abstract][Full Text] [Related]
8. Expanding the Toolkit for Genome Editing in a Disease Vector,
Zhu GH; Albishi NM; Chen X; Brown RL; Palli SR
CRISPR J; 2021 Dec; 4(6):846-853. PubMed ID: 33450159
[TBL] [Abstract][Full Text] [Related]
9. Optimized electroporation of CRISPR-Cas9/gRNA ribonucleoprotein complex for selection-free homologous recombination in human pluripotent stem cells.
Xu H; Kita Y; Bang U; Gee P; Hotta A
STAR Protoc; 2021 Dec; 2(4):100965. PubMed ID: 34825222
[TBL] [Abstract][Full Text] [Related]
10. A protocol for custom CRISPR Cas9 donor vector construction to truncate genes in mammalian cells using pcDNA3 backbone.
Vazquez N; Sanchez L; Marks R; Martinez E; Fanniel V; Lopez A; Salinas A; Flores I; Hirschmann J; Gilkerson R; Schuenzel E; Dearth R; Halaby R; Innis-Whitehouse W; Keniry M
BMC Mol Biol; 2018 Mar; 19(1):3. PubMed ID: 29540148
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas9-Mediated Genomic Deletions Protocol in Zebrafish.
Amorim JP; Bordeira-Carriço R; Gali-Macedo A; Perrod C; Bessa J
STAR Protoc; 2020 Dec; 1(3):100208. PubMed ID: 33377102
[TBL] [Abstract][Full Text] [Related]
12. Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks.
Yang H; Ren S; Yu S; Pan H; Li T; Ge S; Zhang J; Xia N
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899704
[TBL] [Abstract][Full Text] [Related]
13. Chemical-genetic CRISPR-Cas9 screens in human cells using a pathway-specific library.
Hundley FV; Toczyski DP
STAR Protoc; 2021 Sep; 2(3):100685. PubMed ID: 34382013
[TBL] [Abstract][Full Text] [Related]
14. CRISPR deactivation in mammalian cells using photocleavable guide RNAs.
Zou RS; Liu Y; Ha T
STAR Protoc; 2021 Dec; 2(4):100909. PubMed ID: 34746867
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-Cas9 Methods and Key Considerations in the Production of
Sun R; Raban R; Akbari OS
Cold Spring Harb Protoc; 2023 Sep; 2023(9):607-613. PubMed ID: 36931732
[TBL] [Abstract][Full Text] [Related]
16. Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair.
He X; Tan C; Wang F; Wang Y; Zhou R; Cui D; You W; Zhao H; Ren J; Feng B
Nucleic Acids Res; 2016 May; 44(9):e85. PubMed ID: 26850641
[TBL] [Abstract][Full Text] [Related]
17. Protocol for editing fibroblasts with in vitro transcribed Cas9 mRNA and profile off-target editing by optimized GUIDE-seq.
Li Z; Reint G; Haapaniemi EM
STAR Protoc; 2023 Dec; 4(4):102662. PubMed ID: 37889758
[TBL] [Abstract][Full Text] [Related]
18. Silencing of end-joining repair for efficient site-specific gene insertion after TALEN/CRISPR mutagenesis in Aedes aegypti.
Basu S; Aryan A; Overcash JM; Samuel GH; Anderson MA; Dahlem TJ; Myles KM; Adelman ZN
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):4038-43. PubMed ID: 25775608
[TBL] [Abstract][Full Text] [Related]
19. Generation of Efficient Knock-in Mouse and Human Pluripotent Stem Cells Using CRISPR-Cas9.
Anzai T; Hara H; Chanthra N; Sadahiro T; Ieda M; Hanazono Y; Uosaki H
Methods Mol Biol; 2021; 2320():247-259. PubMed ID: 34302663
[TBL] [Abstract][Full Text] [Related]
20. Gene Replacement by Intron Targeting with CRISPR-Cas9.
Li J; Meng X; Li J; Gao C
Methods Mol Biol; 2019; 1917():285-296. PubMed ID: 30610644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
